Euro-BioImaging is organizing an online User Forum on October 6, 2022, from 14:00-17:00 CEST. This event will highlight the importance of cutting-edge imaging technologies in support of fighting infectious diseases and showcase the specific expertise available at our Nodes across Europe through case studies presented in tandem with the research community.
At this event, Hanna Renvall, Aalto University, will speak about recent steps towards novel clinical applications of MEG, including recently launched EU Horizon 2020 project Long COVID on the mechanisms and biomarkers of long-term effects of COVID-19 infection, undertaken in collaboration with the Finnish Biomedical Imaging Node (full abstract below).
Hear this talk and others like it on October 6 at the Euro-BioImaging User Forum: Fighting infectious Diseases.
Hanna Renvall, Aalto University
Tiina Saanijoki, Finnish Biomedical Imaging Node
Noninvasive neuroimaging methods that are based on detecting changes in neural currents (magnetoencephalography, MEG; electroencephalography, EEG) offer efficient means for identifying alterations in brain function beyond structural changes. Especially MEG, with its good temporal and spatial resolution, provides a unique possibility among neuroimaging methods to characterise global cortical networks in both health and disease. In this talk, I will describe recent steps towards novel clinical applications of MEG, including recently launched EU Horizon 2020 project Long COVID on the mechanisms and biomarkers of long-term effects of COVID-19 infection.